Article

Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in…

BioMed Research International · 2020 · Maurizio Battaglia Parodi, author Francesco Romano, author Alessandro Arrigo, author Stefano Mercuri, author Alessandro Franceschi, author Francesco Bandello, author Alfredo García-Layana, Academic Editor

Key facts

Title Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age
First author Maurizio Battaglia Parodi, author Francesco Romano, author Alessandro Arrigo, author Stefano Mercuri, author Alessandro Franceschi, author Francesco Bandello, author Alfredo García-Layana, Academic Editor
Journal BioMed Research International
Published Mar 14, 2020
DOI 10.1155/2020/4747696
Devices mentioned K101223, K113129, K121993, K152205, K172649, K173648, K181594, K182569, K192391, K201252, K223557, K240221 and 1 more
Product codes mentioned HOO, OBO, MYC, MXK, HPT

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature